Trials in Anaheim, California
Here are the top 10 medical studies for colorectal cancer in Anaheim, California
Popular Filters
Phase 3 Trials
PD-L1 Inhibitor
XL092 + Atezolizumab vs Regorafenib for Colorectal Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial is testing a combination of two drugs, XL092 and atezolizumab, against another treatment in patients with a specific type of colorectal cancer that has spread and not responded to standard treatments. The goal is to see if the new combination can better stop cancer growth and help the immune system fight the cancer.
PD-1 Inhibitor
Dostarlimab for Colon Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial is testing dostarlimab, a drug that helps the immune system fight cancer. It targets patients with a specific type of colon cancer that has certain genetic features and can be surgically removed. Dostarlimab works by helping the immune system recognize and destroy cancer cells.
Chemotherapy vs Chemoradiotherapy for Rectal Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial aims to determine if giving chemotherapy alone before limited surgery is as effective as giving chemotherapy and radiation therapy together before surgery in treating rectal cancer. It also seeks to understand if quality of life is
Monoclonal Antibodies
Amivantamab + Chemotherapy vs Cetuximab + Chemotherapy for Colorectal Cancer
Recruiting2 awardsPhase 3
Los Alamitos, California
This trial aims to see how long patients with a specific type of colorectal cancer can remain free of the disease when treated with two different drug combinations.
Trials With No Placebo
Monoclonal Antibodies
DKN-01 for Colorectal Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial tests a new drug, DKN-01, combined with standard chemotherapy and bevacizumab for advanced colorectal cancer patients who didn't respond to earlier treatment. The treatment works by attacking cancer cells, blocking growth signals, and cutting off their blood supply.
Anti-tumor Antibody-drug Conjugate
M9140 for Colorectal Cancer
Recruiting1 awardPhase 1
Encinitas, California
This trial is testing a new drug called M9140 to see if it is safe and effective for patients with advanced solid tumors. Researchers will study how the drug behaves in the body, how well patients can tolerate it, and if it shows any signs of fighting the cancer.
PD-L1 Inhibitor
XL092 + Atezolizumab vs Regorafenib for Colorectal Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial is testing a combination of two drugs, XL092 and atezolizumab, against another treatment in patients with a specific type of colorectal cancer that has spread and not responded to standard treatments. The goal is to see if the new combination can better stop cancer growth and help the immune system fight the cancer.
Chemotherapy
AK112 +/− AK117 for Colorectal Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a new treatment for advanced colorectal cancer that cannot be removed with surgery. The study will investigate how well the treatment works, how safe it is, and how the body processes it
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.